Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases

被引:50
|
作者
Nishiguchi, Gisele A. [1 ]
Atallah, Gordana [1 ]
Bellamacina, Cornelia [1 ]
Burger, Matthew T. [1 ]
Ding, Yu [1 ]
Feucht, Paul H. [2 ]
Garcia, Pablo D. [2 ]
Han, Wooseok [1 ]
Klivansky, Liana [1 ,2 ,3 ]
Lindvall, Mika [1 ]
机构
[1] Novartis Inst BioMed Res, Global Discovery Chem Oncol & Exploratory Chem, Emeryville, CA 94608 USA
[2] Novartis Inst BioMed Res, Oncol Res, Emeryville, CA 94608 USA
[3] Univ Calif Berkeley, Lawrence Berkeley Lab, Mol Foundry, Berkeley, CA 94720 USA
关键词
Pim-kinase inhibitors; Indole; Kinase selectivity; Oncology; PROTOONCOGENE PIM-1; BINDING MODE; CELL; CANCER; PROGRESSION; TUMORIGENESIS; EXPRESSION; APOPTOSIS; LYMPHOMA; SURVIVAL;
D O I
10.1016/j.bmcl.2011.08.105
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel 3,5-disubstituted indole derivatives as potent and selective inhibitors of all three members of the Pim kinase family is described. High throughput screen identified a pan-Pim kinase inhibitor with a promiscuous scaffold. Guided by structure-based drug design, SAR of the series afforded a highly selective indole chemotype that was further developed into a potent set of compounds against Pim-1, 2, and 3 (Pim-1 and Pim-3: IC(50) <= 2 nM and Pim-2: IC(50) <= 100 nM). (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6366 / 6369
页数:4
相关论文
共 50 条
  • [21] Synthesis of novel bioactive pyrido[2, 3-d] pyrimidine derivatives with potent cytotoxicity through apoptosis as PIM-1 kinase inhibitors†
    Department of Chemistry, Faculty of Science, Zagazig University, Zagazig
    44519, Egypt
    不详
    不详
    不详
    13774, Egypt
    RSC Adv., 16 (11098-11111):
  • [22] Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors
    Hu, Huiyong
    Wang, Xiaojing
    Chan, Grace Ka Yan
    Chang, Jae H.
    Do, Steven
    Drummond, Jake
    Ebens, Allen
    Lee, Wendy
    Ly, Justin
    Lyssikatos, Joseph P.
    Murray, Jeremy
    Moffat, John G.
    Chao, Qi
    Tsui, Vickie
    Wallweber, Heidi
    Kolesnikov, Aleksandr
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (22) : 5258 - 5264
  • [23] New Potent and Selective Inhibitor of Pim-1/3 Protein Kinases Sensitizes Human Colon Carcinoma Cells to Doxorubicin
    Moreau, Pascale
    Dezhenkova, Lyubov G.
    Anizon, Fabrice
    Nauton, Lionel
    Thery, Vincent
    Liang, Shuguang
    Kaluzhny, Dmitry N.
    Shtil, Alexander A.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (09) : 1228 - 1236
  • [24] THE POSSIBLE ROLE OF PIM KINASES (PIM1, PIM2 AND PIM3) UPON LIF STIMULATION IN TRANSFORMED TROPHOBLAST CELLS AND CHORIOCARCINOMA CELLS
    Mary, Stella
    Chaiwangyen, Wittaya
    Hoelters, Sebastian
    Fitzgerald, Justine S.
    Markert, Udo R.
    PLACENTA, 2012, 33 (09) : A69 - A69
  • [25] Discovery of Novel Pim-1 Kinase Inhibitors with a Flexible-Receptor Docking Protocol
    Li, Gudong
    Li, Wei
    Xie, Yuting
    Wan, Xiaobo
    Zheng, Guojun
    Huang, Niu
    Zhou, Yu
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2019, 59 (10) : 4116 - 4119
  • [26] New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights
    Lopez-Ramos, Miriam
    Prudent, Renaud
    Moucadel, Virginie
    Sautel, Celine F.
    Barette, Caroline
    Lafanechere, Laurence
    Mouawad, Liliane
    Grierson, David
    Schmidt, Frederic
    Florent, Jean-Claude
    Filippakopoulos, Panagis
    Bullock, Alex N.
    Knapp, Stefan
    Reiser, Jean-Baptiste
    Cochet, Claude
    FASEB JOURNAL, 2010, 24 (09): : 3171 - 3185
  • [27] A crystallographic fragment screen identifies cinnamic acid derivatives as starting points for potent Pim-1 inhibitors
    Schulz, Michele N.
    Fanghaenel, Joerg
    Schaefer, Martina
    Badock, Volker
    Briem, Hans
    Boemer, Ulf
    Nguyen, Duy
    Husemann, Manfred
    Hillig, Roman C.
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2011, 67 : 156 - 166
  • [28] Novel 2-benzylidene benzothiazolidinones as potent and selective inhibitors of protein kinase CK2 and PIM kinases
    Pallela, Venkat R.
    Subbaiah, D. R. C. Venkata
    Mallireddigari, Muralidhar R.
    Akula, Balireddy
    Patti, Revathi
    Bharathi, Vijaya E.
    Cosenza, Stephen C.
    Reddy, E. Premkumar
    Reddy, M. V. Ramana
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [29] Discovery of PIM-1 kinase inhibitors based on the 2,5-disubstituted 1,3,4-oxadiazole scaffold against prostate cancer: Design, synthesis, in vitro and in vivo cytotoxicity investigation
    Castanet, Anne-Sophie
    Nafie, Mohamed S.
    Said, Sara A.
    Arafa, Reem K.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 250
  • [30] Computational analysis of benzofuran-2-carboxlic acids as potent Pim-1 kinase inhibitors
    Wadood, Abdul
    Jamal, Syed Babar
    Riaz, Muhammad
    Mir, Asif
    PHARMACEUTICAL BIOLOGY, 2014, 52 (09) : 1170 - 1178